Jade Biosciences, Inc. (JBIO) › Shareholders' EquityJade Biosciences, Inc. (JBIO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$3.64M2020: -$13.34M2021: $172.42M2022: $126.74M2023: $109.46M2024: -$46.80M2025: $332.52M$332.52M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$332.52M+810.5%2024-$46.80M-142.8%2023$109.46M-13.6%2022$126.74M-26.5%2021$172.42M+1392.1%2020-$13.34M-266.3%2019-$3.64M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share